The breast cancer immune microenvironment is modified by neoadjuvant chemotherapy

Neoadjuvant chemotherapy (NAT) in breast cancer (BC) has been used to reduce tumor burden prior to surgery. However, the impact on prognosis depends on the establishment of Pathological Complete Response (pCR), which is influenced by tumor-infiltrating lymphocyte levels and the activation of the ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Urueña, Claudia, Lasso, Paola, Bernal-Estevez, David, Rubio, Diego, Salazar, Ana Janeth, Olaya, Mercedes, Barreto, Alfonso, Tawil, Mauricio, Torregrosa, Lilian, Fiorentino, Susana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106657/
https://www.ncbi.nlm.nih.gov/pubmed/35562400
http://dx.doi.org/10.1038/s41598-022-12108-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106657/
https://www.ncbi.nlm.nih.gov/pubmed/35562400
http://dx.doi.org/10.1038/s41598-022-12108-5

Ejemplares similares